T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alcon
ALC
|
+$2.11B |
| 2 |
Linde
LIN
|
+$1.34B |
| 3 |
American International
AIG
|
+$1.34B |
| 4 |
Marvell Technology
MRVL
|
+$1.28B |
| 5 |
TSS
Total System Services, Inc.
TSS
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$2.27B |
| 2 |
Eli Lilly
LLY
|
+$1.64B |
| 3 |
NVIDIA
NVDA
|
+$1.59B |
| 4 |
RHT
Red Hat Inc
RHT
|
+$1.55B |
| 5 |
Booking.com
BKNG
|
+$1.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.88% |
| 2 | Healthcare | 16.96% |
| 3 | Financials | 13.79% |
| 4 | Consumer Discretionary | 13.57% |
| 5 | Industrials | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2226
Spectrum Brands
SPB
$2.09B
| $375K | ﹤0.01% |
6,967
-61
| -0.9% | -$3.63K |
|
|
DX
2227
Dynex Capital
DX
$3.23B
| $374K | ﹤0.01% |
22,309
+64
| +0.3% | +$1.13K |
|
2228
Interparfums
IPAR
$3.7B
| $374K | ﹤0.01% |
5,627
+1,442
| +34% | +$101K |
|
|
VIOT
2229
Viomi Technology
VIOT
$48.5M
| $374K | ﹤0.01% |
+46,136
| New | +$477K |
|
|
LAND
2230
Gladstone Land Corp
LAND
$358M
| $373K | ﹤0.01% |
32,318
+41
| +0.1% | +$507 |
|
|
AIMC
2231
DELISTED
Altra Industrial Motion Corp
AIMC
| $373K | ﹤0.01% |
+10,405
| New | +$359K |
|
|
FARM
2232
DELISTED
Farmer Brothers
FARM
| $370K | ﹤0.01% |
22,584
+21
| +0.1% | +$400 |
|
|
DMC
2233
Del Monte Corp
DMC
$1.44B
| $370K | ﹤0.01% |
13,732
+136
| +1% | +$3.71K |
|
|
CAMP
2234
DELISTED
CalAmp Corp.
CAMP
| $370K | ﹤0.01% |
1,377
| – | – |
|
|
DBD
2235
DELISTED
Diebold Nixdorf Incorporated
DBD
| $367K | ﹤0.01% |
40,079
+100
| +0.3% | +$1.04K |
|
|
ACRE
2236
Ares Commercial Real Estate
ACRE
$264M
| $366K | ﹤0.01% |
24,662
| – | – |
|
2237
Century Communities
CCS
$2.04B
| $366K | ﹤0.01% |
13,764
+133
| +1% | +$3.52K |
|
|
ADMS
2238
DELISTED
Adamas Pharmaceuticals
ADMS
| $365K | ﹤0.01% |
58,797
+46,200
| +367% | +$266K |
|
|
SRGA
2239
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $364K | ﹤0.01% |
2,854
+4
| +0.1% | +$576 |
|
2240
Skywest
SKYW
$4.21B
| $362K | ﹤0.01% |
5,959
+99
| +2% | +$5.86K |
|
2241
E.W. Scripps
SSP
$310M
| $362K | ﹤0.01% |
23,658
+628
| +3% | +$11.8K |
|
2242
Werner Enterprises
WERN
$2.31B
| $361K | ﹤0.01% |
11,608
+114
| +1% | +$3.68K |
|
|
CNBKA
2243
DELISTED
Century Bancorp Inc/Mass
CNBKA
| $360K | ﹤0.01% |
4,099
| – | – |
|
2244
Napco Security Technologies
NSSC
$1.37B
| $358K | ﹤0.01% |
24,100
+66
| +0.3% | +$875 |
|
2245
FormFactor
FORM
$10.3B
| $355K | ﹤0.01% |
22,669
+170
| +0.8% | +$2.78K |
|
|
RVNC
2246
DELISTED
Revance Therapeutics, Inc.
RVNC
| $355K | ﹤0.01% |
27,346
+139
| +0.5% | +$1.75K |
|
2247
Griffon
GFF
$4.8B
| $353K | ﹤0.01% |
20,842
-5,342
| -20% | -$91.4K |
|
|
HCR
2248
DELISTED
Hi-Crush Inc. Common Stock
HCR
| $352K | ﹤0.01% |
+142,974
| New | +$447K |
|
|
XOMA
2249
DELISTED
Xoma
XOMA
| $351K | ﹤0.01% |
23,633
-151
| -0.6% | -$2.27K |
|
2250
Franklin Covey
FC
$227M
| $350K | ﹤0.01% |
10,281
+49
| +0.5% | +$1.45K |
|
Similar funds
T. Rowe Price Associates's Q2 2019 Portfolio in Review
As of Q2 2019, T. Rowe Price Associates held 2,600 positions worth $712B, up 4.7% from $680B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
T. Rowe Price Associates's Q2 2019 filing shows 72 new, 1,394 increased, 949 reduced and 59 closed positions. Its largest new stake was Alcon: 36,020,796 shares worth $2.23B. The largest sale was UnitedHealth, an estimated $2.27B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2019 buy was Alcon: 36,020,796 shares worth $2.23B.
- T. Rowe Price Associates added most to Linde in Q2 2019, an estimated $1.34B increase.
- T. Rowe Price Associates's biggest Q2 2019 reduction was UnitedHealth, cutting an estimated $2.27B.
- T. Rowe Price Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $609M.
- T. Rowe Price Associates's ten largest holdings make up 21% of its $712B portfolio in Q2 2019.
- T. Rowe Price Associates opened 72 new positions and closed 59 in Q2 2019.
- T. Rowe Price Associates's portfolio value rose 4.7% quarter-over-quarter to $712B.
Based on T. Rowe Price Associates's 13F filing for Q2 2019, filed 15 Aug 2019.